Wednesday, July 8, 2009

Delaying Generic Drugs Costs Patients & Taxpayers, EU Says

Antitrust investigations are underway involving generic markers Teva and Servier.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)